MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
16 Oct 2019
542
Convey Benevolence and Solve Problems ▕ SCIMEA MDT Committee – Grassroots Academic Promotion
SCIMEA

On September 21, 2019, in order to promote the multidisciplinary research and clinical application of tumor biological immunotherapy, and set up a platform for cancer prevention and control personnel to study tumor biological immunotherapy, promote cooperation and exchange, and improve academic and application skills. "Sichuan International Medical Exchange & Promotion Association (SCIMEA) Oncology Multidisciplinary Therapy (MDT) Committee - Multidisciplinary Comprehensive Treatment in the Age of Biological Immunotherapy – Grassroots Academic Promotion" was held in Jintang County, Chengdu.

The program was sponsored by SCIMEA, organized by MDT Committee of SCIMEA, and co-organized by Jintang County People's Hospital. Professor Wang Qifeng, deputy director physician, Dr. Wu Lei, Wang Yi, and Liang Long, Zhao Yanqun, associate researcher, and Yao Xinghong, assistant researcher from Sichuan Cancer Hospital, Professor Tan Yanlin, director of the Oncology Department of Jintang County People's Hospital, and other experts in oncology participated in the program.

1.jpg

Professor Wang Qifeng

Sichuan Cancer Hospital

[Specifications for Local Advanced NSCLC Diagnosis and Treatment]

The evolution of treatment of local advanced NSCLC; the summary of advantages and safety of immunotherapy; the potential synergy of radiotherapy and immunotherapy in clinical practice.

2.jpg

Wu Lei

Sichuan Cancer Hospital

[Application of Tumor Medicine in Non-Specific Immunotherapy]

The important role of thymus and thymosin hormones in immunity; the efficacy of non-irradiation metastases.

3.jpg

Wang Yi

Sichuan Cancer Hospital

[Status of Esophageal Cancer Immunotherapy]

First-line treatment and second-line treatment of advanced esophageal cancer; exploration of targeted therapy for esophageal cancer; status quo and clinical research of esophageal cancer immunotherapy.

4.jpg

Liang Long

Sichuan Cancer Hospital

[Exploration of the Whole Process Management of Immunotherapy]

The use of immunological checkpoint inhibitors in first-line and second-line treatments; the response and treatment principles of irAEs immunotherapy.

5.jpg

Professor Tan Yanlin

Jintang County People's Hospital

[Immunotherapy Practice and Radiotherapy Quality Control]

Basics and clinical application of immunotherapy; progress in immunotherapy and other aspects; concept of standardized immunotherapy.

6.jpg

Zhao Yanqun

Sichuan Cancer Hospital

[Notes on Radiotherapy Plan]

Four principles of dosimetry, the main radiotherapy technology; targeted average dose and dose cold spots & dose hotspots; assessment on tissue maximum dose and average dose.

7.jpg

Yao Xinghong

Sichuan Cancer Hospital

[Quality Control of Radiotherapy]

Basic procedures, implementation principles, and necessary measures, recognized standards for radiotherapy; precautions for radiotherapy planning; quality, technical requirements and inspection specifications for radiotherapy equipment.

In the afternoon, the experts were divided into small groups to go to the Oncology Department of Jintang County People's Hospital for teaching ward round and guidance, and conducted comprehensive and in-depth analysis and introduction of the construction of a hospital's oncology department, which was highly recognized and praised by local hospital leaders.

8.jpg

Experts exchanged views on typical cases of lung cancer and esophageal cancer. Zeng Hui, Kang Xia, Zhang Hui, Wang Jilin, Shen Biyu, Zeng Yu, Li Huilin, Xi Jiyuan, Liu Cheng and others participated in the case discussion. Through in-depth analysis and detailed answers to challenging questions, the participants gained a lot of knowledge. It opened up their horizon in biological immunotherapy, established a standardized biological immunotherapy concept in their mind, and improved the level of diagnosis and treatment in these grassroots hospitals.

9.jpg

















Interview | Masanori Fukushima: TRI in Dire Need of Exploring Application of TCM with China
Sichuan University's West China Hospital and Other Units Keep on Recruiting Elite Youth Talents
Health Guardian with Dreams | SCIMEA’s Public Welfare Program "Anti-epidemic Experts Speeches in Campus" Held Successfully
​ An Interview with Professor Zhao Yongxiang from Guangxi Medical University
“Letter Home” from Frontline on Lantern Festival, Wishing You Long Life without Sickness!
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1